Xenon Pharmaceuticals Inc. — Investor Relations & Filings
Filings indexed
734
across all filing types
Latest filing
2026-05-07
Regulatory Filings
Country
CA
Canada
Listing
US
XENE
Xenon Pharmaceuticals Inc. is a neuroscience-focused biopharmaceutical company dedicated to the discovery, clinical development, and commercialization of therapeutics for neurological and psychiatric disorders. The company leverages its expertise in human genetics and a deep understanding of ion channel biology to develop medicines that modulate ion channels, targeting the central and peripheral nervous systems. Its late-stage pipeline includes azetukalner, an investigational candidate being developed for the treatment of epilepsy and depression.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - Xenon Pharmaceuticals Inc. (0001582313) (Filer) | 2026-05-07 | English | |
| DEF 14A - Xenon Pharmaceuticals Inc. (0001582313) (Filer) | 2026-04-22 | English | |
| S-8 - Xenon Pharmaceuticals Inc. (0001582313) (Filer) | 2026-04-13 | English | |
| 8-K - Xenon Pharmaceuticals Inc. (0001582313) (Filer) | 2026-04-13 | English | |
| 8-K - XENON PHARMACEUTICALS INC. (0001582313) (Filer) | 2026-02-27 | English | |
| 10-K - XENON PHARMACEUTICALS INC. (0001582313) (Filer) | 2026-02-26 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
14 filings
| |||||
| 43480877 | 8-K - Xenon Pharmaceuticals Inc. (0001582313) (Filer) | 2026-05-07 | English | ||
| 35389182 | DEF 14A - Xenon Pharmaceuticals Inc. (0001582313) (Filer) | 2026-04-22 | English | ||
| 34434906 | S-8 - Xenon Pharmaceuticals Inc. (0001582313) (Filer) | 2026-04-13 | English | ||
| 34434502 | 8-K - Xenon Pharmaceuticals Inc. (0001582313) (Filer) | 2026-04-13 | English | ||
| 32894471 | 8-K - XENON PHARMACEUTICALS INC. (0001582313) (Filer) | 2026-02-27 | English | ||
| 32894472 | 10-K - XENON PHARMACEUTICALS INC. (0001582313) (Filer) | 2026-02-26 | English | ||
| 32894470 | 8-K - XENON PHARMACEUTICALS INC. (0001582313) (Filer) | 2026-02-26 | English | ||
| 30715820 | SCHEDULE 13G Filing | 2026-02-10 | English | ||
| 12697271 | 4 | 2026-01-09 | English | ||
| 12697272 | 4 | 2026-01-09 | English | ||
| 12697273 | 4 | 2026-01-09 | English | ||
| 12697274 | 4 | 2026-01-09 | English | ||
| 12697275 | 4 | 2026-01-02 | English | ||
| 12697276 | Regulatory Filings 2026 | 2026-01-02 | English | ||
|
2025
1 filing
| |||||
| 12697277 | 4 | 2025-12-10 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
Xenon Pharmaceuticals Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31373/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31373 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31373 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31373 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31373}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Xenon Pharmaceuticals Inc. (id: 31373)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.